The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Veracyte
Genomic landscape of FNAs positive for medullary thyroid cancer (MTC) and potential impact on systemic therapy.
 
Lori J. Wirth
Consulting or Advisory Role - Amgen; Ayala Pharmaceuticals; Blueprint Medicines; CUE Biopharma; Eisai; Loxo; Merck; Novartis
Other Relationship - Iovance Biotherapeutics
 
Steven G. Waguespack
No Relationships to Disclose
 
Naifa Lamki Busaidy
Consulting or Advisory Role - Eisai; Loxo
Research Funding - GlaxoSmithKline/Novartis
 
Mimi I-Nan Hu
Consulting or Advisory Role - Blueprint Medicines; Loxo
 
Elizabeth Gardner Grubbs
No Relationships to Disclose
 
Steven P Weitzman
No Relationships to Disclose
 
Mark Zafereo
No Relationships to Disclose
 
Joshua Babiarz
No Relationships to Disclose
 
Yangyang Hao
Employment - Veracyte
Stock and Other Ownership Interests - Veracyte
 
Jing Huang
Employment - Veracyte
 
Giulia Kennedy
Employment - Veracyte
Stock and Other Ownership Interests - Veracyte
 
P. Sean Walsh
Employment - Veracyte
 
Richard Kloos
Employment - Veracyte
Stock and Other Ownership Interests - Veracyte